Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

October 20, 2015October 20, 2015

UCSD Scientists and Illumina Team Up to Create Human Microbiome Data Platform

News

The human microbiome has been the subject of increasing research, with scientists determined to unravel its role in a wide range of conditions including obesity, asthma, allergies, and inflammatory conditions ... Read more

October 19, 2015September 28, 2016

enGene Announces Partnership with Janssen Biotech to Develop New Therapies for Inflammatory Bowel Diseases

News

enGene, Inc., a privately held biotechnology company developing a versatile non-viral vector platform for gene delivery through its proprietary technology “Gene Pill”, recently announced that it has made a decisive ... Read more

October 14, 2015October 14, 2015

NIH Grants $1.35 Million for Research on Food Emulsifiers Impact in Chronic Inflammatory Diseases

News

A Georgia State University professor has been recently granted $1.35 million by The National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to ... Read more

October 12, 2015October 12, 2015

Study Reveals a Higher Risk for Invasive Pneumococcal Disease among IBD Patients

News

A new study from Statens Serum Institut in Copenhagen, Denmark reports that Inflammatory Bowel Disease (IBD) patients present a higher risk of invasive pneumococcal disease (IPD), before and after diagnosis. ... Read more

October 5, 2015October 5, 2015

AstraZeneca’s AZD9056 Shows Promise in Phase IIa Study on Moderate to Severe Crohn’s Disease

News

According to a recently published study, AstraZeneca’s AZD9056 – an orally-available purinergic receptor P2X7 antagonist, may be effective in symptom improvement in patients with moderate to severe Crohn’s disease. The study is ... Read more

September 29, 2015September 26, 2016

Curcumin-Loaded Microparticles Show Promise as an Effective Oral Treatment for Ulcerative Colitis

News

Researchers at the Institute for Biomedical Sciences at Georgia State University and Southwest University in China have developed a new oral drug to treat ulcerative colitis. The study, published in ... Read more

September 24, 2015September 24, 2015

Study Suggests IBD Patients Only Need to Undergo Colonoscopy Up to Every 5 Years

News

There has been substantial debate on the issue of how often one should undergo surveillance colonoscopy procedures to detect colorectal cancer (CRC) at an early stage and improve survival. Recent ... Read more

September 23, 2015September 23, 2015

MIT Researcher Works with Sewage to Study Inflammatory Bowel Disease

News

A fourth-year PhD research student in computational and systems biology at MIT, Mariana G. Matus, is collecting sewage samples with the goal of understanding community behavior and health. “It’s not something ... Read more

September 22, 2015September 22, 2015

Pfizer Reports Favorable Results on Oral Tofacitinib for Ulcerative Colitis

News

Pfizer recently released the top-line results from two Phase III induction studies of twice-daily tofacitinib (10 mg tablets) for ulcerative colitis, within the Oral Clinical Trials for tofAcitinib in ulceratiVE colitis (OCTAVE) global ... Read more

September 21, 2015September 21, 2015

Nestlé Health Science Licenses Rights for LT-02 as Ulcerative Colitis Therapy

News

Nestlé Health Science recently announced that it has entered into a license partnership with Lipid Therapeutics, a biopharmaceutical company focused on the development and commercialization of phospholipids, for global exclusive ... Read more